SparkRx: The first digital therapeutic for adolescents
pharmaphorum
MAY 9, 2022
SparkRx is designed to decrease depression in individuals aged 13 to 22 by providing a multi-week programme based on cognitive behavioural therapy (CBT) and behavioural activation protocols. “In In primary care, there are guidelines to screening for behavioural health concerns like depression annually. About the author .
Let's personalize your content